Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.35 |
| ▸ | PTPRC | P08575 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15662355 | 1.00 | ALDH1A1 (0.54) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL15662815 | 1.00 | ALDH1A1 (0.54) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL16577756 | 1.00 | ALDH1A1 (0.54) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17700993 | 0.98 | ALDH1A1 (0.52) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5918737 | 0.96 | ALDH1A1 (0.54) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL66251 | 0.96 | ALDH1A1 (0.54) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL15525343 | 0.96 | ALDH1A1 (0.46) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL18859311 | 0.95 | ALDH1A1 (0.45) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL8577005 | 0.94 | ALDH1A1 (0.43) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5918721 | 0.93 | ALDH1A1 (0.46) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0031054-B1 | SOIL DISINFECTANT COMPOSITION, A METHOD FOR PREVENTING AND CONTROLLING DISEASES IN SOIL AND CERTAIN PHENYLPHOSPHINIC ACID SALTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-02-29 | — | — | EP | claimed |
| US-20240294761-A1 | DUAL CURE ORGANOPOLYSILOXANE COMPOSITION WITH SHELF-LIFE STABILITY | DOW SILICONES CORPORATION | 2024-09-05 | — | — | US | disclosed |
| US-20230347333-A1 | Membranes | FUJIFILM CORPORATION (JP) | 2023-11-02 | — | — | US | disclosed |
| WO-2020126263-A1 | MOULDED PART AND CROSSLINKABLE COMPOSITION FOR FORMING THE MOULDED PART | REHAU AG + CO (DE) | 2020-06-25 | — | — | WO | disclosed |
| US-9713585-B2 | Nail coatings having enhanced adhesion | CREATIVE NAIL DESIGN, INC. (US) | 2017-07-25 | — | — | US | disclosed |
| US-20170056313-A1 | NAIL COATINGS HAVING ENHANCED ADHESION | CREATIVE NAIL DESIGN, INC. (US) | 2017-03-02 | — | — | US | disclosed |
| US-20160109209-A1 | LENS FOR SIGHTING DEVICE | FERGUSON RICKY C (US) | 2016-04-21 | — | — | US | disclosed |
| US-20160067164-A1 | NAIL COATINGS HAVING ENHANCED ADHESION | MUFG BANK LTD. AS AGENT | 2016-03-10 | — | — | US | disclosed |
| EP-2988721-A1 | NAIL COATINGS HAVING ENHANCED ADHESION | Creative Nail Design, Inc. (US) | 2016-03-02 | — | — | EP | disclosed |
| US-9194657-B1 | Lens for sighting device | FERGUSON RICKY C (US) | 2015-11-24 | — | — | US | disclosed |
| WO-2014176275-A1 | NAIL COATINGS HAVING ENHANCED ADHESION | CREATIVE NAIL DESIGN, INC. (US) | 2014-10-30 | — | — | WO | disclosed |
| EP-1948288-A2 | BALLOON CATHETER WITH ELASTIC SEGMENT | Abbott Laboratories Vascular Enterprises Limited (IE) | 2008-07-30 | — | — | EP | disclosed |
| EP-1292641-B1 | Use of polyamide compositions | LANXESS DEUTSCHLAND GMBH (DE) | 2007-10-03 | — | — | EP | disclosed |
| WO-2007054364-A2 | BALLOON CATHETER WITH ELASTIC SEGMENT | ABBOTT LABORATORIES VASCULAR ENTERPRISES LIMITED (IE) | 2007-05-18 | — | — | WO | disclosed |
| US-6803394-B2 | ACRYLATED POLYURETHANE; PROTECTIVE COATINGS | GEL PRODUCTS, INC. | 2004-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160067164-A1 | NAIL COATINGS HAVING ENHANCED ADHESION | PIK3C3, POLR1C, NACA | ALDH1A1 2316/4885MAPK1 3158/4885NPC1 4854/4885 |
| US-20170056313-A1 | NAIL COATINGS HAVING ENHANCED ADHESION | POLR1C, PIK3C3, NACA | ALDH1A1 1567/4885MAPK1 3333/4885NPC1 4881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.